Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 137
Filtrar
1.
Gynecol Oncol ; 108(3): 569-76, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18222533

RESUMO

BACKGROUND: Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) contribute to the invasiveness of many carcinomas. Here, we studied a possible association between cytosolic uPA and PA-1 concentrations in tumor tissue with prognosis in patients with endometrial cancer. METHODS: Cytosolic concentrations of uPA and PAI-1 were determined in 69 primary endothelial adenocarcinomas using an enzyme-linked immunoassay (ELISA). A possible influence of uPA and PAI-1 was studied by multivariate Cox regression adjusting for the established clinical prognostic factors FIGO-stage, grading, depth of invasion, diabetes mellitus and age. RESULTS: Both uPA (p=0.011) and PAI-1 (p=0.003) were associated with relapse free time using the multivariate proportional hazards model. Association with overall survival was less pronounced with p=0.021 for uPA and p=0.358 for PAI-1. Concentrations of PAI-1 increased with FIGO stage (p=0.003) and with histological grading (p=0.005). Both uPA and PAI-1 concentrations were negatively correlated with estrogen and progesterone receptor levels. CONCLUSION: The combination of high cytosolic concentrations of uPA (>5 ng/mg total protein) and high PAI-1 (>20 ng/mg total protein) may reveal a group of patients with increased risk of progression.


Assuntos
Adenocarcinoma/metabolismo , Biomarcadores Tumorais/metabolismo , Neoplasias do Endométrio/metabolismo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Adenocarcinoma/mortalidade , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Intervalo Livre de Doença , Neoplasias do Endométrio/mortalidade , Neoplasias do Endométrio/patologia , Neoplasias do Endométrio/cirurgia , Feminino , Alemanha/epidemiologia , Humanos , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Prognóstico , Análise de Sobrevida
2.
Clin Hemorheol Microcirc ; 37(3): 211-8, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17726250

RESUMO

Thromboembolic complications remain an important cause of maternal mortality. The present recommendations favour for prophylaxis unfractionated (UFH) and low molecular weight heparin (LMWH). We investigated 150 pregnant women before and after cesarean section in three randomized groups. Fifty women received no prophylaxis (group I), 50 women UFH two times 5000 IU/day (group III) and 50 women Dalteparin 5000 U/day (group II). We determined the blood count, the rheological parameters and cholesterol, triglycerides, D-dimer, fibrinogen and the anti-Xa-level. We found a classical hemodilution, with increase of erythrocyte aggregation and plasma viscosity postoperatively. The fibrinogen turnover and D-dimer concentration were elevated. The patients with Dalteparin prophylaxis showed lower thrombin activation, minor changes in the cholesterol and triglycerides level and an improvement of red cell deformability in low shear regions. Our results demonstrated an influence of Dalteparin on the rheological parameters post surgery. The DVT incidence was 1.33% generally and occurred only in the Control group and in women with unfractionated heparin. We observed no side effects such as major bleeding, osteopenia or allergy.


Assuntos
Cesárea/efeitos adversos , Hemorreologia/efeitos dos fármacos , Heparina de Baixo Peso Molecular/administração & dosagem , Heparina/administração & dosagem , Adulto , Biomarcadores/sangue , Coagulação Sanguínea/efeitos dos fármacos , Viscosidade Sanguínea , Dalteparina/administração & dosagem , Feminino , Humanos , Incidência , Complicações Pós-Operatórias/prevenção & controle , Gravidez , Pré-Medicação , Trombose Venosa/etiologia
3.
Clin Appl Thromb Hemost ; 12(2): 227-9, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16708127

RESUMO

Hemorrhagic shock developed in a 29-year-old nullipara without coagulopathy after emergency caesarean section. Treatment with uterotonic drugs, prostaglandins, and conservative procedures with transfusion of packed red cells and fresh-frozen plasma failed to control the diffuse vaginal and uterine bleeding. Finally an intravenous bolus injection of 90 microg/kg recombinant activated factor VII (rFVIIa, NovoSeven, Novo Nordisk A/S, Bagsvaerd, Denmark), was given and showed success within 20 minutes after administration, without any side effects.


Assuntos
Cesárea/efeitos adversos , Fator VII/uso terapêutico , Hemorragia Pós-Parto/tratamento farmacológico , Adulto , Estado Terminal , Fator VIIa , Feminino , Humanos , Hemorragia Pós-Parto/terapia , Gravidez , Proteínas Recombinantes/uso terapêutico , Resultado do Tratamento
4.
Zentralbl Gynakol ; 127(2): 99-101, 2005 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-15800842

RESUMO

Severe postmenopausal virilization is a rare event in clinical practice. To evaluate ovarian or adrenal hyperandrogenism endocrine tests and imaging are useful diagnostic tools. We report a case of a postmenopausal woman with hirsutism and androgenetic alopecia. A malignant cause for the present disorder could be excluded by imaging. Selective venous sampling was administered with increased testosterone level of the right adrenal vein. Right adrenalectomy and right oophorctomy was recommended.


Assuntos
Testosterona/metabolismo , Virilismo/etiologia , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Ovariectomia , Pós-Menopausa , Testosterona/sangue
5.
Clin Hemorheol Microcirc ; 32(3): 183-90, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15851837

RESUMO

Hemorheological parameters were determined in 45 pairs of mothers with severe preeclampsia and their newborns in comparison with 45 women with uncomplicated pregnancies and their newborns. In both groups we investigated red cell deformability, the plasma viscosity, the red cell aggregation (during stasis and low flow), the macromolecules fibrinogen and factor VIIIR:Ag (VWF), and the blood count parameters hemoglobin, hematocrit, white cells, platelets, reticulocytes, MCV, MCHC. Cholesterol and triglycerides were correlated to the parameter of red cell deformability measured as red cell elongation. We found a significant lower plasma viscosity, red cell aggregation, fibrinogen, cholesterol, triglycerides and VWF in cord blood with a close association between plasma viscosity and fibrinogen (r = 0.56, p = 0.001). The red cell deformability measured as red cell elongation was statistically higher in the cord blood compared to the mothers and associated with a higher MCV. In contrast the MCHC values remained unchanged. Hematocrit and hemoglobin in the cord blood were higher than in the mothers. The incidence of fetal hyperviscosity-polycytemia syndrome in women with severe preeclampsia was between 4.7% and 4.9%. An elevated red cell aggregation was found in 2.8% (stasis) and 4.8% (low flow state), respectively. We conclude that in fetal blood the higher hematocrit and the presence of larger red cells do not cause impaired fetal hemorheology.


Assuntos
Pré-Eclâmpsia/diagnóstico , Complicações Cardiovasculares na Gravidez , Plaquetas/metabolismo , Agregação Eritrocítica , Deformação Eritrocítica , Índices de Eritrócitos , Eritrócitos/citologia , Feminino , Sangue Fetal/metabolismo , Fibrinogênio/biossíntese , Hematócrito , Hemoglobinas/metabolismo , Hemorreologia/métodos , Humanos , Concentração de Íons de Hidrogênio , Recém-Nascido , Leucócitos/citologia , Gravidez , Reticulócitos/metabolismo , Triglicerídeos/metabolismo , Fator de von Willebrand/biossíntese
6.
Z Geburtshilfe Neonatol ; 209(1): 29-33, 2005 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-15731978

RESUMO

BACKGROUND: Prematurity is a main issue in modern obstetrical care. The purpose of the present study was to evaluate the perinatal outcome of premature infants weighing less than 1500 g according to the mode of delivery. PATIENTS AND METHODS: 122 patients with infants weighing less than 1500 g were enrolled in this retrospective study (26 to 32 weeks of gestation). The perinatal outcomes of 26 infants born by vaginal delivery were compared to 96 infants delivered by caesarean section. RESULTS: The rates of rupture of membranes, preterm labour and intravenous tocolysis were significantly increased in patients after vaginal delivery. Preeclampsia and pathological cardiotocograms were increased in patients after caesarean section. Infants born by vaginal delivery showed a significant increase of peri- and intraventricular haemorrhage grade III, periventricular leukomalacia, C-reactive protein 24 hours postpartum and mortality until the seventh day of life. However, the rate of bronchopulmonary dysplasia was significantly increased in infants born by caesarean section (p < 0.05). CONCLUSIONS: These data suggest that the mode of delivery affects the perinatal outcome of infants weighing less than 1500 g. Based on the results of the present study, it appears unclear which mode of delivery should be preferred, depending on particular material and fetal factors.


Assuntos
Cesárea/mortalidade , Mortalidade Infantil , Doenças do Prematuro/mortalidade , Recém-Nascido de muito Baixo Peso , Parto Normal/mortalidade , Medição de Risco/métodos , Alemanha/epidemiologia , Humanos , Recém-Nascido , Fatores de Risco , Análise de Sobrevida
7.
Zentralbl Gynakol ; 126(3): 148-53, 2004 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-15236099

RESUMO

OBJECTIVE: Are serum concentrations of the ovarian glycoproteins inhibin A, inhibin B, pro-alpha-C and activin A different in normotensive, chronical hypertensive or pregancies complicated by preeclampsia or HELLP-syndrome? What are the clinical consequences? METHODS: Serum concentrations of inhibin A, inhibin B, pro-alpha-C, and activin A of 99 women (37 normotensive patients, 23 patients with chronical hypertension, 25 women with preeclampsia and 14 patients with HELLP-syndrome) at different stages of pregnancy were determined by high specific ELISAS. RESULTS: During pregnancy serum levels of all parameters increased continually and fell rapidly within parturition. Activin A and inhibin B levels showed significant higher serum concentrations in patients with preeclampsia and - even more pronounced - in patients with HELLP-syndrome. Normotensive and chronically hypertensive patients were not different. CONCLUSION: Activin A and inhibin A appear to be viable candidates as laboratory parameters for detection of pregnancy induced hypertension. Maybe furthermore both parameters will allow the discrimination between chronic hypertension and hypertension induced by pregnancy.


Assuntos
Ativinas/uso terapêutico , Síndrome HELLP/tratamento farmacológico , Subunidades beta de Inibinas/uso terapêutico , Inibinas/uso terapêutico , Complicações na Gravidez/tratamento farmacológico , Feminino , Humanos , Hipertensão/tratamento farmacológico , Pré-Eclâmpsia/tratamento farmacológico , Gravidez , Complicações Cardiovasculares na Gravidez/tratamento farmacológico
8.
Clin Hemorheol Microcirc ; 31(1): 49-58, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15272153

RESUMO

The objective of this study was to determine the differences of hemorheological parameters in association to haematological tests in patients with severe preeclampsia (blood pressure (diastolic) > 100 mm Hg, blood pressure (systolic) > 180 mm Hg and proteinuria > 3 g/24 h). Blood samples of 45 primigravidas by hospital admission were studied. The control group were 45 pregnant women--age and weight matched--with normal blood pressure and without obstetric complications. We measured red cell aggregation (stasis, low shear), red cell elongation with the ectacytometer, blood cell indices (Hct, Hbg, MCV, MCHC, reticulocytes, white cells, platelets), fibrinogen haptoglobin and factor VIIIR:Ag, cholesterol and triclycerides. In comparison between patients with severe preeclampsia and normal pregnant women we found statistically elevated values of hematocrit, hemoglobin, red cell aggregation (stasis, low shear rate), MVC and factor VIIIR:Ag. Non-significant changes were observed in values of plasma viscosity, white cells, platelets, haptoglobin, MCHC, reticulocytes, triglycerides and cholesterol. The red cell deformability measured as cell elongation was statistically reduced by high shear stress application in patients with severe preeclampsia. Our results suggest that hemorheological parameters play an important role in severe preeclampsia, especially at microcirculatory regions with high shear stress such as intervillous space of placenta.


Assuntos
Pressão Sanguínea/fisiologia , Deformação Eritrocítica , Hemorreologia/métodos , Pré-Eclâmpsia/sangue , Pré-Eclâmpsia/fisiopatologia , Adulto , Viscosidade Sanguínea , Colesterol/sangue , Agregação Eritrocítica , Feminino , Idade Gestacional , Humanos , Idade Materna , Gravidez , Proteinúria , Valores de Referência , Estresse Mecânico , Sístole , Triglicerídeos/sangue
9.
Exp Clin Endocrinol Diabetes ; 112(5): 278-80, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15146375

RESUMO

In modern day health care, Sheehan's syndrome is a rare disorder affecting the postpartum period. We present a case of a 33-year-old woman with atonic hemorrhage developing a transient Sheehan's syndrome associated with hyponatremia six days postpartum. Evaluation of cranial computer tomography and magnetic resonance imaging of the pituitary demonstrated normal finding. Immediate replacement therapy using sodium, chloride, hydrocortisone, fludrocortisone and levothyroxine revealed regression of the Sheehan's syndrome to complete recovery. The present report shows that Sheehan's syndrome can be associated with hyponatremia and illustrates the need to include hyponatremia as an initial symptom in the differential diagnosis of Sheehan's syndrome.


Assuntos
Hiponatremia/etiologia , Hipopituitarismo/diagnóstico , Transtornos Puerperais/etiologia , Adulto , Cesárea , Cloretos/sangue , Feminino , Humanos , Trabalho de Parto , Gravidez , Sódio/sangue
10.
Zentralbl Gynakol ; 125(11): 441-5, 2003 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-14634872

RESUMO

There is common agreement about the importance of information management systems in obstetrics and gynecology. Those systems are necessary tools for medical quality management and are essential for the actual preparation for the age of the "diagnosis related groups" that will be introduced in Germany next year. Nevertheless there are only small scientifically activities to improve information management systems and to evaluate their performance. Great efforts are necessary to develop new features and not to loose the conflict between the needs of the physicians and their patients and the needs and demands of hospital administrative authorities.


Assuntos
Ginecologia/tendências , Informática Médica/tendências , Obstetrícia/tendências , Feminino , Ginecologia/normas , Humanos , Relações Interprofissionais , Informática Médica/normas , Obstetrícia/normas , Relações Médico-Paciente , Gravidez
11.
Z Geburtshilfe Neonatol ; 207(4): 132-6, 2003.
Artigo em Alemão | MEDLINE | ID: mdl-14528415

RESUMO

BACKGROUND: Preeclampsia is a pregnancy-induced multiorganic disease. The incidence is 5 - 7 % in all pregnant women. To assess the value of circadian blood pressure rhythm in preeclamptic women, 24-hour blood pressure monitoring might be useful. The purpose of this study was to determine the predictive value of circadian blood pressure rhythm for the maternal and obstetrical outcome in patients with mild preeclampsia. PATIENTS AND METHODS: Sixty-six patients with mild preeclampsia underwent 24-hour blood pressure monitoring between 29 and 39 weeks gestation. Twenty-eight patients with normal circadian blood pressure rhythm were compared with thirty-eight patients with suspended circadian blood rhythm. RESULTS: There was no difference in age, body mass index, gravidity, parity, miscarriage, or fetal outcome between the two groups. The rate of secondary caesarean section was 39.5 % in the suspended circadian blood pressure group and 21.4 % in the normal circadian blood pressure group, respectively (P = 0.03). CONCLUSIONS: In patients with mild preeclampsia, the circadian blood pressure rhythm appears to be unsuitable as a screening test. Further research is required for more etiological and pathophysiological insights into the development of clinically useful tools with predictive value.


Assuntos
Monitorização Ambulatorial da Pressão Arterial , Pressão Sanguínea/fisiologia , Cesárea , Ritmo Circadiano/fisiologia , Complicações do Trabalho de Parto/fisiopatologia , Pré-Eclâmpsia/fisiopatologia , Resultado da Gravidez , Adolescente , Adulto , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Cardiotocografia , Feminino , Humanos , Recém-Nascido , Metildopa/uso terapêutico , Complicações do Trabalho de Parto/diagnóstico , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/tratamento farmacológico , Valor Preditivo dos Testes , Gravidez , Segundo Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Prognóstico , Fatores de Risco
12.
Zentralbl Gynakol ; 123(8): 454-7, 2001 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-11562809

RESUMO

Internet presentations are common tools for better medical communication and better scientific work. Meanwhile a great number of gynecological and obstetrical institutions present data via the world wide web within a wide range of quality and performance. Specific HTML editors offer quick and easy presentations, but only advanced internet techniques enable interesting multimedia presentations. N-tier applications are the future standard and we must integrate them in general informatical systems. New Concepts, actual tools and general problems will be discussed and new principles similar to actual E commerce techniques are able to solve our special medical demands.


Assuntos
Ginecologia/educação , Internet , Obstetrícia/educação , Segurança Computacional , Feminino , Alemanha , Humanos , Recém-Nascido , Multimídia , Gravidez , Software
13.
J Perinat Med ; 29(1): 23-30, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11234613

RESUMO

It has been assumed that low birth weight and high placenta weight were key factors for predicting hypertension in human adulthood. A deficiency in placental 11 beta-HSD-II enzyme activity was supposed to be the underlying cause. To possibly establish 11 beta-HSD-II as a leading factor, we determined 11 beta-HSD-II activities in 133 healthy pregnancies, 21 proteinuric pregnancies complicated by pregnancy-induced hypertension (PIH), 26 non proteinuric PIH pregnancies and 15 pregnancies complicated by fetal growth restriction (32nd-41st gestational week). We could not identify differences in 11 beta-HSD-II activity between pregnancies with the rare combination of small babies with big placentas and others (p = 0.59; Kruskal-Wallis test). And although there was no correlation between 11 beta-HSD-II activity and birth weight, in the control gestational age correlated with 11 beta-HSD-II activity (r = 0.22; p < 0.05; Spearman). 11 beta-HSD-II activity in the proteinuric PIH group was significantly higher than in the controls (11.7 pmol/min/mg prot.; range 10-13.2 vs. 7.9; range 7.0-9.1; p < 0.05). The lowest, but not significant, enzyme activities were in the IUGR group (5.8 pmol/min/mg prot.; range 4.0-9.2). In this group, analysis of variance detected a correlation between enzyme activity and placental weight. In conclusion, we could not confirm that placental 11 beta-HSD-II deficiencies act as an indicator for the risk of adult hypertension in small fetuses with large placentas. However, in growth restriction 11 beta-HSD-II activity might play a role. To clarify the influence in this group, further research is needed. Increased 11 beta-HSD-II activities with gestational age in the control may serve to sustain fetal adrenal steroid genesis and to prepare the fetus for autonomic life.


Assuntos
Peso ao Nascer , Hidroxiesteroide Desidrogenases/metabolismo , Hipertensão/enzimologia , Isoenzimas/metabolismo , Placenta/anatomia & histologia , Placenta/enzimologia , 11-beta-Hidroxiesteroide Desidrogenases , Citosol/enzimologia , Feminino , Retardo do Crescimento Fetal/enzimologia , Idade Gestacional , Humanos , Modelos Lineares , Microssomos/enzimologia , Tamanho do Órgão , Gravidez , Complicações Cardiovasculares na Gravidez/enzimologia , Proteinúria/enzimologia
14.
Fertil Steril ; 75(1): 32-7, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11163813

RESUMO

OBJECTIVE: To investigate the influence of human recombinant follicle-stimulating hormone (FSH) on circulating serum concentrations of the ovarian proteohormones inhibin A, inhibin B, pro alpha-C, and activin A and serum levels of estradiol after down-regulation with GnRH analogue. DESIGN: Serum concentrations of ovarian proteohormones and estradiol. SETTING: Academic clinical practice. PATIENT(S): 30 women who underwent assisted reproductive techniques. INTERVENTION(S): Blood samples were analyzed for inhibin A, inhibin B, pro alpha-C, activin A, and estradiol during IVF treatment at points coinciding with pituitary down-regulation, stimulation with recombinant FSH, ovulatory triggering, and the luteal phase of the cycle. RESULT(S): Activin A levels did not change with recombinant FSH stimulation. In women with a sonographically detected leading follicle >17 mm in diameter, levels of inhibin A, pro alpha-C, and estradiol increased significantly (P<.05). The increase in inhibin B level was not statistically significant. In patients without adequate follicle development during FSH stimulation, serum levels of inhibins remained low and did not significantly deviate from values measured before stimulation. CONCLUSION(S): Inhibin A and pro alpha-C are effective markers of follicular development and may be effective additions to estradiol as a marker.


Assuntos
Fertilização in vitro , Hormônio Foliculoestimulante/efeitos adversos , Inibinas/sangue , Ativinas , Adulto , Regulação para Baixo/efeitos dos fármacos , Estradiol/biossíntese , Feminino , Hormônio Foliculoestimulante/antagonistas & inibidores , Humanos , Fase Luteal/efeitos dos fármacos , Folículo Ovariano/diagnóstico por imagem , Ovulação/efeitos dos fármacos , Gravidez , Proteínas Recombinantes/efeitos adversos , Ultrassonografia
15.
Clin Hemorheol Microcirc ; 25(3-4): 83-9, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11847411

RESUMO

We examined the hemodynamic and hemorheological effects of intravenous volume expansion in women with pre-eclampsia. 20 untreated women with moderate pre-eclampsia were randomized to receive a 500 ml infusion over 4 h of either hydroxyethylstarch (HAES steril 10%, HES) or NaCl 0.9% solution. After completion of the infusion trial all patients received oral antihypertensive drugs, bed rest and free sodium and water intake. The hemodynamic responses were measured by impedance cardiography. Hemorheological parameters and blood pressure were measured before and after (24 h later) infusion. The HES infusion but not NaCl leads to a significant reduction of hematocrit and erythrocyte aggregation. In addition to that there was a nonsignificant increase of the cardiac index in the HES-group but no changes in the heart rate. Intravenous volume expansion in women with pre-eclampsia with a long acting colloid like hydroxyethylstarch is associated with a significant influence on the flow properties (hematocrit and erythrocyte aggregation) of blood.


Assuntos
Hidratação , Hemodinâmica/efeitos dos fármacos , Hemorreologia/efeitos dos fármacos , Derivados de Hidroxietil Amido/uso terapêutico , Substitutos do Plasma/uso terapêutico , Pré-Eclâmpsia/terapia , Adolescente , Adulto , Viscosidade Sanguínea/efeitos dos fármacos , Coloides/farmacologia , Coloides/uso terapêutico , Soluções Cristaloides , Agregação Eritrocítica/efeitos dos fármacos , Feminino , Fibrinogênio/análise , Hematócrito , Humanos , Derivados de Hidroxietil Amido/farmacologia , Soluções Isotônicas , Substitutos do Plasma/farmacologia , Gravidez , Reprodutibilidade dos Testes , Cloreto de Sódio/farmacologia , Cloreto de Sódio/uso terapêutico , Resultado do Tratamento
16.
Eur J Endocrinol ; 143(1): 77-84, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10870034

RESUMO

OBJECTIVE: Interest has focused recently on the influences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. DESIGN: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 microg gonadorelin, in 19 women with ovulatory disturbances. METHODS: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. RESULTS: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0.001). Activin A showed a significant decrease from 0.47 to 0.36 ng/ml (P < 0.001), whereas pro alpha-C increased from 127 to 156 pg/ml (P = 0.039). The median inhibin A concentration did not show a significant change between baseline and the 60 min value, whereas inhibin B was characterized by a minor, but not significant, increase in the median from 168 to 179 pg/ml (P = 0.408). A significant inverse correlation (P = 0.014) with a mean coefficient of correlation of 0.5516 was found, demonstrating a strong relationship between high inhibin B baseline levels and a small increase of FSH after 60 min. CONCLUSION: Our results show an interesting correlation between the baseline inhibin B and the change in FSH before and after GnRH stimulation. A high baseline inhibin B implies only a minor increase of FSH after 60 min.


Assuntos
Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina , Inibinas/sangue , Doenças Ovarianas/sangue , Ativinas , Adolescente , Adulto , Amenorreia/sangue , Amenorreia/etiologia , Estradiol/sangue , Feminino , Humanos , Hipogonadismo/etiologia , Doenças Hipotalâmicas/complicações , Hormônio Luteinizante/sangue
17.
Zentralbl Gynakol ; 122(4): 230-3, 2000.
Artigo em Alemão | MEDLINE | ID: mdl-10795122

RESUMO

While computer applications are widely accepted in clinical chemical departments, small numbers of computer systems are used in gynecological endocrinological laboratories. Modern applications should be integrated in local area networks and clinical information systems that improve communication and data exchange within hospitals and the outer resources. Better communication may improve medical quality and will lead to a better therapy for gynecological endocrinological patients.


Assuntos
Sistemas de Informação em Laboratório Clínico , Endocrinologia , Ginecologia , Redes Locais , Sistemas Computadorizados de Registros Médicos , Segurança Computacional , Sistemas Computacionais , Feminino , Alemanha , Humanos
18.
Zentralbl Gynakol ; 122(3): 153-9, 2000.
Artigo em Alemão | MEDLINE | ID: mdl-10756599

RESUMO

OBJECTIVE: The purpose of this study was to determine whether the tumor suppressor gene p53 can be used as a prognosis factor to assess individual patient risk in primary ovarian carcinoma. MATERIALS AND METHODS: The concentration of the mutated, as well as the wild type p53 was examined in 98 cases of ovarian carcinoma. Among 98 ovarian tumors examined, 77 were primary carcinomas, 14 tumors were metastasis of foreign tumors, and 7 were benign ovarian tumors. The pan-53 ELISA from Fa. Dianova was used to test for the p53 protein. RESULTS: The p53 protein concentration exhibited a wide range in the different tissue samples. Benign tumors contained significantly lower p53 concentrations than malignant tumors. After the data was analyzed using Kaplan-Meier, a p53 concentration of 507.1 pg/ml was established as cut-off point for assessing cancer prognosis as good or poor. Patients exhibiting p53 concentrations over 507.1 pg/ml had a median life expectancy of 20 months, and patients exhibiting lower tumor concentrations of p53 had a life expectancy of over 70 months. A significant relationship between patient life expectancy could also be shown for tumor stage and type, whereas not for tumor grading. CONCLUSIONS: Based on the results of this study, the routine measurement of p53 may allow for a better prognostic assessment of life expectancy of patients with primary ovarian carcinoma.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma/química , Genes p53/genética , Mutação , Neoplasias Primárias Desconhecidas/química , Neoplasias Ovarianas/química , Proteína Supressora de Tumor p53/análise , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Carcinoma/genética , Carcinoma/patologia , Carcinoma/cirurgia , Ensaio de Imunoadsorção Enzimática , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Expectativa de Vida , Pessoa de Meia-Idade , Neoplasia Residual/química , Neoplasia Residual/patologia , Neoplasias Primárias Desconhecidas/genética , Neoplasias Primárias Desconhecidas/patologia , Neoplasias Primárias Desconhecidas/cirurgia , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/patologia , Neoplasias Ovarianas/cirurgia , Valor Preditivo dos Testes , Prognóstico , Análise de Sobrevida , Proteína Supressora de Tumor p53/genética
19.
Zentralbl Gynakol ; 122(3): 160-4, 2000.
Artigo em Alemão | MEDLINE | ID: mdl-10756600

RESUMO

OBJECTIVE: In which way is the biochemical analysis of fine needle biopsy comparable to the biochemical analysis of conventional surgical biopsy samples in the examination of prognosis factors in mammary carcinomas. MATERIAL AND METHODS: Conventional surgical biopsy and fine needle biopsy were performed on 63 mammary carcinomas. The results from the biochemical analysis of tissue samples, from each form of biopsy, with respect to estradiol and progesterone receptor, UPA and PAI-1, as well as Kathepsin D and the EGF receptor, were compared and statistically analyzed. RESULTS: When compared to conventional tissue biopsy samples, the sensitivity and specificity of the measured prognosis factors in fine needle biopsy tissue were variable for each parameter, but fell within the statistically safe margin of 86 to 100%. CONCLUSIONS: The biochemical analysis of the prognosis factors found in fine needle biopsy samples showed that fine needle biopsy is a viable alternative to intraoperative conventional surgical biopsy.


Assuntos
Biomarcadores Tumorais/análise , Biópsia/métodos , Neoplasias da Mama/química , Neoplasias da Mama/diagnóstico , Mama/patologia , Biópsia por Agulha , Mama/química , Neoplasias da Mama/patologia , Catepsina D/análise , Receptores ErbB/análise , Feminino , Humanos , Inibidor 1 de Ativador de Plasminogênio/análise , Prognóstico , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Estudos de Amostragem , Sensibilidade e Especificidade , Ativador de Plasminogênio Tipo Uroquinase/metabolismo
20.
Zentralbl Gynakol ; 121(10): 473-8, 1999.
Artigo em Alemão | MEDLINE | ID: mdl-10573820

RESUMO

OBJECTIVE: The present study was to measure new prognostic factors including the plasminogen activator urokinase and the plasminogen inhibitor PAI-1, as well as p53 and Ki-67, a marker of proliferation and to compare the clinical value of these in relation to the classic histopathological prognostic factors. MATERIAL AND METHODS: The patient collective included 45 patients with vulvar carcinoma, both primary tumors and recurrences. RESULTS: Highly significant correlations were found for tumor diameter and thickness. According to Kaplan-Meier estimations, the influence of thickness on the prognosis had a p-value of 0.048, while the influence of diameter had a p-value of 0.029. The variable grading was also significantly associated to the probability of survival (p = 0.01). There was no statistically significant correlation between p53 and the parameters grading, degree of keratinization and Ki-67 color index. The correlation between p53 and PAI-1 as well as between UPA and PAI-1 was highly significant. According to the Kaplan-Meier estimations, Ki-67, UPA and PAI-1 had no influence on survival in our group of patients. CONCLUSIONS: For p53, the median value could be used as a divider with the median survival of patients with a p53 below 122 pg/mg protein being 151 months and with a p53 above 122 pg/mg being only 61 months. The corresponding p-value was significant at 0.0201.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma de Células Escamosas/patologia , Neoplasias Vulvares/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/mortalidade , Feminino , Humanos , Antígeno Ki-67/análise , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Inibidor 1 de Ativador de Plasminogênio/análise , Prognóstico , Taxa de Sobrevida , Proteína Supressora de Tumor p53/análise , Ativador de Plasminogênio Tipo Uroquinase/análise , Vulva/patologia , Neoplasias Vulvares/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...